Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development

25Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Metabolism plays a critical role in direct regulation of a variety of cellular activities via metabolic enzymes and metabolites. Here, we demonstrate that phosphofructokinase 1 platelet isoform (PFKP), which catalyzes a rate-limiting reaction in glycolysis, promotes EGFR activation-induced nuclear translocation and activation of β-catenin, thereby enhancing the expression of its downstream genes CCND1 and MYC in human glioblastoma cells. Importantly, we showed that EGFR-phosphorylated PFKP Y64 has a critical role in AKT activation and AKT-mediated β-catenin S552 phosphorylation and subsequent β-catenin transactivation and promotion of tumor cell glycolysis, migration, invasion, proliferation, and brain tumor growth. These findings highlight a novel mechanism underlying a glycolytic enzyme-mediated β-catenin transactivation and underscore the integrated and reciprocal regulation of metabolism and gene expression, which are two fundamental biological processes in tumor development.

Cite

CITATION STYLE

APA

Lee, J. H., Shao, F., Ling, J., Lu, S., Liu, R., Du, L., … Lu, Z. (2020). Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.00211

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free